GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TSH Biopharm Corp Ltd (ROCO:8432) » Definitions » Short-Term Capital Lease Obligation

TSH Biopharm (ROCO:8432) Short-Term Capital Lease Obligation : NT$7 Mil (As of Sep. 2024)


View and export this data going back to 2012. Start your Free Trial

What is TSH Biopharm Short-Term Capital Lease Obligation?

TSH Biopharm's Short-Term Capital Lease Obligation for the quarter that ended in Sep. 2024 was NT$7 Mil.

TSH Biopharm's quarterly Short-Term Capital Lease Obligation increased from Mar. 2024 (NT$6 Mil) to Jun. 2024 (NT$8 Mil) but then declined from Jun. 2024 (NT$8 Mil) to Sep. 2024 (NT$7 Mil).

TSH Biopharm's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (NT$5 Mil) to Dec. 2022 (NT$7 Mil) and increased from Dec. 2022 (NT$7 Mil) to Dec. 2023 (NT$7 Mil).

TSH Biopharm Short-Term Capital Lease Obligation Historical Data

The historical data trend for TSH Biopharm's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TSH Biopharm Short-Term Capital Lease Obligation Chart

TSH Biopharm Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.22 4.37 4.57 7.32 7.40

TSH Biopharm Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.54 7.40 5.56 8.22 7.45

TSH Biopharm Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

TSH Biopharm Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of TSH Biopharm's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

TSH Biopharm Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TSH Biopharm Corp Ltd (ROCO:8432) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
TPE:3054 ROCO:6817 ROCO:1780 ROCO:4172 ROCO:4117 ROCO:6496 ROCO:6935 ROCO:6677 TPE:1731 ROCO:7561 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
No.3-1, Park Street, 3rd Floor-1, Nangang District, Taipei, TWN, 115
Website
https://www.tshbiopharm.com
TSH Biopharm Corp Ltd is engaged in the sale of a variety of pharmaceuticals, chemical drugs and biotechnology services. The Company's revenue is earned domestically. It earns majority of its revenue from the sale of Lozenges.

TSH Biopharm Headlines

No Headlines